The Pivotal Moment for Digital Therapeutics
Next-Generation Digital Healthcare
Since 2017, The DTx Series has been the meeting point for those striving to define and advance validated-digital healthcare. As the industry moves into a new era, so does the series, which maintains its core goal: to bring together leaders from across healthcare to accelerate the next generation of digital health approaches into the hands of patients in need. Continuing to be built with the community, The DTx Series will continue to provide unrivaled learnings and networking opportunities around the biggest challenges and opportunities the industry is facing.
Since 2017, The DTx Series has been the meeting point for those striving to define and advance validated-digital healthcare. As the industry moves into a new era, so does the series, which maintains its core goal: to bring together leaders from across healthcare to accelerate the next generation of digital health approaches into the hands of patients in need. Continuing to be built with the community, The DTx Series will continue to provide unrivaled learnings and networking opportunities around the biggest challenges and opportunities the industry is facing.
Who will be there?
The event brings together a diverse audience of digital therapeutics professionals from pharma, biotech, and academia, offering a unique blend of practical insights, networking opportunities, and cutting-edge presentations.
The event brings together a diverse audience of digital therapeutics professionals from pharma, biotech, and academia, offering a unique blend of practical insights, networking opportunities, and cutting-edge presentations.
Benefits of attending:
Core topics on the agenda include reimbursement, investment, pharmaceutical partnerships, evidence standards, the payer perspective, the role of AI and hand-picked case studies.
Core topics on the agenda include reimbursement, investment, pharmaceutical partnerships, evidence standards, the payer perspective, the role of AI and hand-picked case studies.
